CN114190578A - Tobacco tar with tranquilizing effect and preparation method thereof - Google Patents
Tobacco tar with tranquilizing effect and preparation method thereof Download PDFInfo
- Publication number
- CN114190578A CN114190578A CN202111466806.6A CN202111466806A CN114190578A CN 114190578 A CN114190578 A CN 114190578A CN 202111466806 A CN202111466806 A CN 202111466806A CN 114190578 A CN114190578 A CN 114190578A
- Authority
- CN
- China
- Prior art keywords
- tobacco tar
- caffeine
- parts
- tranquilizing effect
- additive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 38
- 230000002936 tranquilizing effect Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 244000061176 Nicotiana tabacum Species 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 52
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- 241000208125 Nicotiana Species 0.000 claims abstract description 37
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 27
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229960001948 caffeine Drugs 0.000 claims abstract description 26
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 26
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000654 additive Substances 0.000 claims abstract description 13
- 230000000996 additive effect Effects 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 17
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 15
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 15
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 15
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 15
- 229940116229 borneol Drugs 0.000 claims description 15
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 15
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 13
- 229960004063 propylene glycol Drugs 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 210000002345 respiratory system Anatomy 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 2
- 235000019640 taste Nutrition 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 8
- 239000003571 electronic cigarette Substances 0.000 abstract description 6
- 241000208134 Nicotiana rustica Species 0.000 abstract description 3
- 208000019901 Anxiety disease Diseases 0.000 abstract description 2
- 206010057852 Nicotine dependence Diseases 0.000 abstract description 2
- 208000025569 Tobacco Use disease Diseases 0.000 abstract description 2
- 230000036506 anxiety Effects 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 7
- 238000005303 weighing Methods 0.000 description 5
- 230000000949 anxiolytic effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000779 smoke Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 3
- 239000002249 anxiolytic agent Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 3
- 229960002715 nicotine Drugs 0.000 description 3
- 241000984061 Aquilaria Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 241001534930 Thymelaeaceae Species 0.000 description 2
- -1 alkyl carbon Chemical compound 0.000 description 2
- 230000000049 anti-anxiety effect Effects 0.000 description 2
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- 241001533085 Aquilaria sinensis Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/285—Treatment of tobacco products or tobacco substitutes by chemical substances characterised by structural features, e.g. particle shape or size
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides tobacco tar with tranquilizing and allaying excitement functions and a preparation method thereof, which relate to the field of electronic cigarettes and comprise the following components: the liquid comprises a base liquid and an additive, wherein glycerol and/or propylene glycol are mixed to serve as the base liquid, and the additive at least comprises Bugenfuran and caffeine; the addition amount of the Buge furan is 0.1-2% by mass percent; the addition amount of the caffeine is 0.1-5% by mass percentage. The tobacco tar provided by the invention has comfortable taste and good safety, can be used for replacing nicotine tobacco tar, can relieve nicotine addiction, has the functions of tranquilizing, soothing nerves, resisting anxiety and the like, and is simple in preparation method, easy to operate and suitable for industrial production.
Description
Technical Field
The invention relates to the field of electronic cigarettes, in particular to tobacco tar with a tranquilizing effect and a preparation method thereof.
Background
The development direction of the tobacco tar of the electronic cigarette at present is as follows: the method simulates the real cigarette taste, simulates various fruity tastes, improves the safety, reduces the production cost and the like. Few research teams are concerned about the health care and medicinal value of e-cigarettes. At present, no published data discloses a technical scheme for performing anti-anxiety physiotherapy by using an electronic cigarette.
In carrying out the present invention, the applicant has found that: aquilaria sinensis is a traditional rare traditional Chinese medicine, is a wood core which is infected by fungi and contains precipitation resin of Aquilaria (Aquilaria) plants in Thymelaeaceae (Thymelaeaceae), and is listed as the top grade in Shen nong Ben Cao Jing. The compendium of materia Medica records: the lignum Aquilariae Resinatum has effects of refreshing mind, invigorating qi, and coordinating mind. Chemical composition analysis of agilawood has been reported, and mainly focuses on the research of agilawood essential oil. Six classes of compounds are reported by domestic and foreign chemists in turn, such as: benzyl acetone, hydrogenated cinnamic acid, linalool, linalol spiro ring, and agarofuran.
The literature reports that the agarofuran compound and the derivative thereof have anxiolytic effect and mild central nervous inhibition effect. When the number of the alkyl carbon at the 4-position is 4-6, the anxiolytic effect and the central sedative and hypnotic effect are obvious (Vol.13, No.3, P125, Chinese journal of medicinal chemistry), and compared with the activity of a plurality of derivatives in the central nervous system, the bullofuran has the strongest anxiolytic and sedative effects. The Bugrefuran also has good prevention and treatment effects on drug addiction (application of CN111939149A Bugrefuran in preparing drugs for preventing and/or treating amphetamine drug addiction-related diseases).
But no technical scheme for applying the bulgafuran to the electronic cigarette tobacco tar exists at present. The technical difficulty is as follows: the BuGe furan is unstable at room temperature, 6% of impurities are generated in an accelerated experiment (30 ℃ and 60% RH) for 3 months, namely, the tobacco tar added with the BuGe furan is not easy to store and transport and is not convenient to popularize, and in addition, the BuGe furan is unstable after being dissolved in an organic solvent and is not easy to be delivered into a human body in an atomization mode.
Therefore, how to improve the stability of the bulgur so that the bulgur can exert the antianxiety physical therapy value in the electronic cigarette tobacco tar is a technical problem to be solved urgently.
Disclosure of Invention
The invention aims to at least solve one of the technical problems in the prior art or the related technology, and provides tobacco tar with the effects of tranquilizing and allaying excitement and a preparation method thereof, which can improve the stability of bugol, improve the taste, have good safety, can replace nicotine tobacco tar for use, can relieve nicotine addiction, and has the functions of tranquilizing, allaying excitement, resisting anxiety and the like.
The invention is realized by the following technical scheme:
the invention discloses tobacco tar with tranquilizing and allaying excitement function, which comprises the following components: the base liquid comprises glycerol and/or propylene glycol, and is used as atomized liquid for carrying the additive into a respiratory system; the additive at least comprises brewage furan and caffeine; the addition amount of the Buge furan is 0.1-2% by mass percent; the addition amount of the caffeine is 0.1-5% by mass percentage.
In the technical scheme, the caffeine is a xanthine alkaloid compound with a chemical formula of C8H10N4O2The chemical structural formula is as follows:
bugrefuran is an agarofuran compound. The compound has obvious anxiolytic effect, low toxic and side effects and wide market prospect, and the chemical structural formula of the bulgafuran is as follows:
the Bugenfuran is oily liquid, has strong fat solubility, is insoluble in water, and can be dissolved in glycerol and 1, 2-propylene glycol. The invention adds the bugol into the tobacco tar to ensure that the tobacco tar has the functions of tranquilizing and allaying excitement and assisting sleep, and the stability of the bugol is obviously improved after the caffeine is added into the tobacco tar.
According to the above technical solution of the present invention, preferably, the additive further includes: the mass percentage of the borneol is less than or equal to 3 percent.
In the technical scheme, the borneol has auxiliary functions of seasoning, cooling and diminishing inflammation, and is beneficial to improving the taste of tobacco tar after entering the mouth.
According to the above technical solution of the present invention, preferably, the additive further includes: the mint is less than or equal to 2 percent in percentage by mass.
In the technical scheme, the mint has auxiliary functions of seasoning, cooling and diminishing inflammation, and is beneficial to improving the taste of the tobacco tar after entering the mouth.
According to the above technical solution of the present invention, preferably, the method further includes: a nicotine substitute capable of simulating a nicotine "throat-strike" sensation.
According to the above technical solution of the present invention, preferably, the method further includes: essence capable of simulating fruit taste or tobacco taste in an atomized state.
According to the above technical solution of the present invention, preferably, the content of caffeine is greater than the content of bregfuran.
According to the above technical solution of the present invention, preferably, the content of caffeine is less than the content of bregfuran.
According to the above technical solution of the present invention, preferably, when the borneol and the mint are added simultaneously, the content of the borneol is greater than that of the mint.
According to the above technical solution of the present invention, preferably, the base liquid specifically includes: 10 parts of glycerol and 10 parts of 1, 2-propylene glycol in parts by mass.
According to the above technical solution of the present invention, preferably, the additive specifically includes: 2 parts of brix, 2 parts of caffeine, 3 parts of borneol and 2 parts of mint in parts by mass.
The invention also discloses a preparation method of the tobacco tar with the tranquilizing effect, which comprises the following steps: preparing raw materials according to the component proportion of the tobacco tar with the tranquilizing effect disclosed by any one of the technical schemes; shaking the base solution uniformly; adding the bulgaricus, and uniformly stirring; adding the fine ground caffeine powder, stirring and dissolving.
The beneficial effects obtained by the invention at least comprise: the stability of the bulgafuran is obviously improved after the caffeine is added into the tobacco tar, and the mint and the borneol are added to achieve the effects of opening orifices, dissipating stagnated fire, reducing swelling, relieving pain and the like, increase the smoke feeling and the taste and also promote the stability of the bulgafuran.
Detailed Description
In order that the above objects, features and advantages of the present invention can be more clearly understood, the present invention will be described in further detail with reference to specific embodiments.
Example 1
One embodiment of the invention discloses tobacco tar with tranquilizing effect, which comprises the following components: 10g of glycerol, 10g of 1, 2-propylene glycol, 0.2g of bulgafuran, 0.2g of caffeine, 0.3g of borneol and 0.2g of mint.
The preparation method comprises the following steps: respectively weighing 10g of glycerol and 10g of 1, 2-propylene glycol, mixing uniformly, adding 0.2g of bugol, stirring uniformly, adding 0.2g of ground caffeine, 0.3g of borneol and 0.2g of mint, and stirring for dissolving to obtain the final product.
In the embodiment, the added mint component can disperse wind and heat, clear head and eyes, relieve sore throat, and has an excitation effect after the mint enters a human body, can stimulate central nerves and indirectly conduct to peripheral nerves, dilate respiratory capillary vessels, and enhance the absorption of the human body to the buge furan.
Example 2
In another embodiment of the present invention, a tobacco tar with tranquilizing effect is disclosed, comprising: 10g of glycerol, 5g of 1, 2-propylene glycol, 0.3g of bulgafuran and 0.75g of caffeine.
The preparation method comprises the following steps: respectively weighing 10g of glycerol and 5g of 1, 2-propylene glycol, uniformly mixing, adding 0.3g of bugol, uniformly stirring, adding 0.75g of ground caffeine, and stirring for dissolving to obtain the product.
Example 3
In another embodiment of the present invention, a tobacco tar with tranquilizing effect is disclosed, comprising: 10g of glycerol, 0.01g of bulgafuran, 0.1g of caffeine, 0.3g of borneol and 0.2g of mint.
The preparation method comprises the following steps: weighing 10g of glycerol, adding 0.01g of bulgafuran, stirring uniformly, adding 0.2g of ground caffeine, 0.3g of borneol and 0.2g of mint, and stirring for dissolving to obtain the finished product.
Comparative example 1:
comparative example 1 was prepared according to the formulation of example 1, except that caffeine, borneol and peppermint were removed. Respectively weighing 10g of glycerol and 1, 2-propylene glycol, uniformly mixing, adding 0.2g of bulgur, and uniformly stirring to obtain the finished product.
Comparative example 2:
comparative example 2 was prepared according to the formulation of example 1, except that borneol and peppermint were removed. Respectively weighing 10g of glycerol and 1, 2-propylene glycol, uniformly mixing, adding 0.2g of bugol, uniformly stirring, adding 0.2g of ground caffeine, and stirring for dissolving to obtain the product.
Comparative experiment:
the samples of example 1, comparative example 1 and comparative example 2 are respectively added into a smoke bomb, the smoke bomb is placed for 3 months under the condition of accelerated experiment (30 ℃ and 60% RH), samples are respectively taken for 1 month, 2 months and 3 months to detect the impurity content, and the stability of the tobacco tar is examined, and the results are as follows:
in conclusion, the stability of the bugol is improved by adding the caffeine into the tobacco tar, and the mint and the borneol are added to achieve the effects of dredging orifices, dispelling stagnated fire, relieving swelling, relieving pain and the like, increase the smoke feeling and the taste and promote the stability of the bugol. Compared with the traditional tobacco tar, the tobacco tar with the effects of tranquilizing and allaying excitement disclosed by the invention has the advantages that the taste is improved, the safety is good, the tobacco tar can be used instead of nicotine tobacco tar, the addiction of nicotine can be relieved, and the functions of tranquilizing, allaying excitement and the like are realized.
The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (9)
1. A tobacco tar with tranquilizing effect comprises base fluid and additive, and is characterized in that,
the base liquid comprises glycerol and/or propylene glycol, and is used as atomized liquid for carrying the additive into a respiratory system;
the additive at least comprises brewage furan and caffeine;
the addition amount of the Buge furan is 0.1-2% by mass percent;
the addition amount of the caffeine is 0.1-5% by mass percent.
2. The tobacco tar with tranquilizing effect according to claim 1, wherein the additive further comprises: the mass percentage of the borneol is less than or equal to 3 percent.
3. The tobacco tar with tranquilizing effect according to claim 1 or 2, wherein the additive further comprises: the mint is less than or equal to 2 percent in percentage by mass.
4. The tobacco tar with tranquilizing effect according to claim 1, wherein the content of caffeine is greater than the content of bregfuran.
5. The tobacco tar with tranquilizing effect according to claim 1, wherein the content of caffeine is less than the content of bregfuran.
6. The tobacco tar with tranquilizing effect according to claim 3, wherein when Borneolum Syntheticum and herba Menthae are added simultaneously, the content of Borneolum Syntheticum is greater than that of herba Menthae.
7. The tobacco tar with tranquilizing effect according to claim 1, wherein the base fluid specifically comprises: 10 parts of glycerol and 10 parts of 1, 2-propylene glycol in parts by mass.
8. The tobacco tar with tranquilizing effect according to claim 1, wherein the additive specifically comprises: 2 parts of brix, 2 parts of caffeine, 3 parts of borneol and 2 parts of mint in parts by mass.
9. A preparation method of tobacco tar with tranquilizing effect is characterized by comprising the following steps:
preparing raw materials according to the component proportion of the tobacco tar with the tranquilizing effect of any one of claims 1 to 8;
shaking the base solution uniformly;
adding the bulgaricus, and uniformly stirring;
adding the fine ground caffeine powder, stirring and dissolving.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111466806.6A CN114190578A (en) | 2021-12-03 | 2021-12-03 | Tobacco tar with tranquilizing effect and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111466806.6A CN114190578A (en) | 2021-12-03 | 2021-12-03 | Tobacco tar with tranquilizing effect and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114190578A true CN114190578A (en) | 2022-03-18 |
Family
ID=80650328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111466806.6A Pending CN114190578A (en) | 2021-12-03 | 2021-12-03 | Tobacco tar with tranquilizing effect and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114190578A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114869875A (en) * | 2022-05-12 | 2022-08-09 | 天津港保税区有维生物科技有限公司 | Application of Bugenfuran in preparation of smoking cessation product |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002012217A1 (en) * | 2000-05-12 | 2002-02-14 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments |
| CN101926505A (en) * | 2010-08-09 | 2010-12-29 | 深圳市如烟生物科技有限公司 | Caffeine electronic cigarette liquid |
| CN103519352A (en) * | 2013-11-07 | 2014-01-22 | 袁恩泽 | Electronic cigarette |
| CN104026731A (en) * | 2014-07-01 | 2014-09-10 | 安徽中烟工业有限责任公司 | Heart nourishing and nerve soothing functional electronic cigarette juice |
| CN105011349A (en) * | 2014-04-30 | 2015-11-04 | 上海绿馨电子科技有限公司 | Electronic cigarette oil containing agilawood extract and preparation method thereof |
| CN105433428A (en) * | 2014-09-01 | 2016-03-30 | 上海羿康生物科技有限公司 | Atomized liquid containing caffeine and production method for atomized liquid containing caffeine |
| CN106108113A (en) * | 2016-06-28 | 2016-11-16 | 熊轶 | A kind of electronic cigarette tobacco tar with gum health effect and preparation method thereof |
-
2021
- 2021-12-03 CN CN202111466806.6A patent/CN114190578A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002012217A1 (en) * | 2000-05-12 | 2002-02-14 | Institute Of Materia Medica, Chinese Academy Of Medical Sciences | New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments |
| CN101926505A (en) * | 2010-08-09 | 2010-12-29 | 深圳市如烟生物科技有限公司 | Caffeine electronic cigarette liquid |
| CN103519352A (en) * | 2013-11-07 | 2014-01-22 | 袁恩泽 | Electronic cigarette |
| CN105011349A (en) * | 2014-04-30 | 2015-11-04 | 上海绿馨电子科技有限公司 | Electronic cigarette oil containing agilawood extract and preparation method thereof |
| CN104026731A (en) * | 2014-07-01 | 2014-09-10 | 安徽中烟工业有限责任公司 | Heart nourishing and nerve soothing functional electronic cigarette juice |
| CN105433428A (en) * | 2014-09-01 | 2016-03-30 | 上海羿康生物科技有限公司 | Atomized liquid containing caffeine and production method for atomized liquid containing caffeine |
| CN106108113A (en) * | 2016-06-28 | 2016-11-16 | 熊轶 | A kind of electronic cigarette tobacco tar with gum health effect and preparation method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 中国医学科学院药物研究所: "《中草药现代研究第五卷》", 31 December 2010, 中国协和医科大学出版社 * |
| 杨明等: "《中医香疗学》", 28 February 2019, 中国中医药出版社 * |
| 梅全喜: "《香药-沉香》", 30 July 2016, 中国中医药出版社 * |
| 马世昌等: "《化学物质词典》", 30 April 1999, 陕西科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114869875A (en) * | 2022-05-12 | 2022-08-09 | 天津港保税区有维生物科技有限公司 | Application of Bugenfuran in preparation of smoking cessation product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kalix | Catha edulis, a plant that has amphetamine effects | |
| KR101667952B1 (en) | Plant extract compositions for affecting sleep | |
| US20090155392A1 (en) | Methods and Systems for Sublingual Guarana Administration | |
| CN107233412A (en) | It is a kind of to promote compound essential oil composition of sleep and its production and use | |
| CN109364124A (en) | It is a kind of spraying and preparation method thereof with sedative-hypnotic property | |
| CN101229247B (en) | Medicine preparation for treating insomnia and preparing method thereof | |
| CN101297867B (en) | Cigarette for quitting drug and preparation thereof | |
| CN114190578A (en) | Tobacco tar with tranquilizing effect and preparation method thereof | |
| CN110624029A (en) | Traditional Chinese medicine composition for resolving depression, calming heart and soothing nerves and preparation method of external patch | |
| CN116672427A (en) | Natural plant volatile oil for relieving dizziness and headache as well as preparation method and application thereof | |
| DE202004018534U1 (en) | Herbal composition for side-effect free treatment of depression, comprising herbs or herbal extracts for promoting blood flow and reducing coagulated blood levels, calming, sedation and flow of Qi | |
| CN106266561A (en) | A kind of Sugarless type liver-benefiting eye-brightening oral liquid and preparation method thereof | |
| US8962040B2 (en) | Vaporized medicants and methods of use | |
| CN100430045C (en) | Radix bupleuri dripping pill and its preparing method | |
| CN104027439A (en) | Composition and preparation method thereof | |
| CN107485673A (en) | Liquid for stopping smoking using Cortex Magnoliae Officinalis tribulus terrestris etc. or its extraction component as main formula | |
| CN112121095A (en) | Hypnotic essential oil composition with quick response and preparation method thereof | |
| CN107028941A (en) | A kind of sleep aid and preparation method thereof and application method, atomizer | |
| CN114984121B (en) | A Chinese medicinal composition with effects of refreshing and relieving fatigue, and its preparation method and application | |
| CN1171546C (en) | Medicine for inhibiting harmful matter in cigarette and its prepn process | |
| CN113908210B (en) | Traditional Chinese medicine anti-anxiety bag and preparation method thereof | |
| CN114869875A (en) | Application of Bugenfuran in preparation of smoking cessation product | |
| CN113893276B (en) | Sleep improving composition, and preparation method and application thereof | |
| CN113749279A (en) | Coffee-flavored refreshing cigarette oil and preparation method thereof | |
| KR101817761B1 (en) | Composition containing acontitie tuber and sulfurprecipitatum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220318 |
|
| RJ01 | Rejection of invention patent application after publication |